Role of the familial Dutch mutation E22Q in the folding and aggregation of the 15–28 fragment of the Alzheimer amyloid-β protein

Amyloid fibrils, large ordered aggregates of amyloid β proteins (Aβ), are clinical hallmarks of Alzheimer's disease (AD). The aggregation properties of amyloid β proteins can be strongly affected by single-point mutations at positions 22 and 23. The Dutch mutation involves a substitution at position 22 (E22Q) and leads to increased deposition rates of the AβE22Q peptide onto preseeded fibrils. We investigate the effect of the E22Q mutation on two key regions involved in the folding and aggregation of the Aβ peptide through replica exchange molecular dynamics simulations of the 15–28 fragment of the Aβ peptide. The Aβ15–28 peptide encompasses the 22–28 region that constitutes the most structured part of the Aβ peptide (the E22–K28 bend), as well as the central hydrophobic cluster (CHC) (segment 17–21), the primary docking site for Aβ monomers depositing onto fibrils. Our simulations show that the 22–28 bend is preserved in the Aβ(15–28) peptide and that the CHC, which is mostly unstructured, interacts with this bend region. The E22Q mutation does not affect the structure of the bend but weakens the interactions between the CHC and the bend. This leads to an increased population of β-structure in the CHC. Our analysis of the fibril elongation reaction reveals that the CHC adopts a β-strand conformation in the transition state ensemble, and that the E22Q mutation increases aggregation rates by lowering the barrier for Aβ monomer deposition onto a fibril. Thermodynamic signatures of this enhanced fibrillization process from our simulations are in good agreement with experimental observations.

[1]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[2]  R. Tycko,et al.  Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.

[3]  D. van der Spoel,et al.  GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .

[4]  R. Nussinov,et al.  Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ16–22, Aβ16–35, and Aβ10–35): Sequence effects , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Iwata,et al.  The Alzheimer's peptide a beta adopts a collapsed coil structure in water. , 2000, Journal of structural biology.

[6]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997 .

[7]  J. Straub,et al.  Charge states rather than propensity for β‐structure determine enhanced fibrillogenesis in wild‐type Alzheimer's β‐amyloid peptide compared to E22Q Dutch mutant , 2002 .

[8]  S. Greenberg,et al.  Pathogenic Effects of D23N Iowa Mutant Amyloid β-Protein* , 2001, The Journal of Biological Chemistry.

[9]  S. Constantinescu,et al.  Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42. , 2006, Biochemistry.

[10]  R. Wetzel,et al.  Polymorphism in the intermediates and products of amyloid assembly. , 2007, Current opinion in structural biology.

[11]  L. Lannfelt,et al.  Unique Physicochemical Profile of β-Amyloid Peptide Variant Aβ1–40E22G Protofibrils: Conceivable Neuropathogen in Arctic Mutant Carriers , 2004 .

[12]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..

[13]  M. Nagao,et al.  Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease. , 2003, The Journal of biological chemistry.

[14]  P. Kollman,et al.  Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models , 1992 .

[15]  Yuko Okamoto,et al.  Replica-exchange Monte Carlo method for the isobaric isothermal ensemble , 2001 .

[16]  J. Melchor,et al.  Charge alterations of E22 enhance the pathogenic properties of the amyloid-β protein , 2000, Neurobiology of Aging.

[17]  George B. Benedek,et al.  Temperature dependence of amyloid β-protein fibrillization , 1998 .

[18]  Joan-Emma Shea,et al.  The structure of the Alzheimer amyloid beta 10-35 peptide probed through replica-exchange molecular dynamics simulations in explicit solvent. , 2007, Journal of molecular biology.

[19]  B Frangione,et al.  Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. , 2000, The Journal of biological chemistry.

[20]  R. Friesner,et al.  Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .

[21]  J R Ghilardi,et al.  Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. , 2000, Biochemistry.

[22]  D. Selkoe,et al.  Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein. , 1992, Biochemistry.

[23]  W. V. Van Nostrand,et al.  Charge Alterations of E22 Enhance the Pathogenic Properties of the Amyloid β‐Protein , 2000 .

[24]  P. Lansbury,et al.  Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.

[25]  Yilin Yan,et al.  The Alzheimer's peptides Abeta40 and 42 adopt distinct conformations in water: a combined MD / NMR study. , 2007, Journal of molecular biology.

[26]  Ruth Nussinov,et al.  Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process. , 2007, Biophysical journal.

[27]  N. Mousseau,et al.  The conformations of the amyloid-beta (21-30) fragment can be described by three families in solution. , 2006, The Journal of chemical physics.

[28]  Andrij Baumketner,et al.  Structure of the 21–30 fragment of amyloid β‐protein , 2006 .

[29]  H. Vinters,et al.  Point Substitution in the Central Hydrophobic Cluster of a Human β-Amyloid Congener Disrupts Peptide Folding and Abolishes Plaque Competence† , 1996 .

[30]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[31]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[32]  Andreas Vitalis,et al.  Quantitative characterization of intrinsic disorder in polyglutamine: insights from analysis based on polymer theories. , 2007, Biophysical journal.

[33]  R. Leapman,et al.  A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Nagao,et al.  Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1-42 mutants of familial Alzheimer's disease at positions 21-23. , 2002, Biochemical and biophysical research communications.

[35]  J R Ghilardi,et al.  Activation barriers to structural transition determine deposition rates of Alzheimer's disease a beta amyloid. , 2000, Journal of structural biology.

[36]  D. Teplow,et al.  On the nucleation of amyloid β‐protein monomer folding , 2005 .

[37]  C. Soto,et al.  The -Helical to -Strand Transition in the Amino-terminal Fragment of the Amyloid -Peptide Modulates Amyloid Formation * , 1995, The Journal of Biological Chemistry.

[38]  H. Stanley,et al.  Folding events in the 21-30 region of amyloid β-protein (Aβ) studied in silico , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Berk Hess,et al.  GROMACS 3.0: a package for molecular simulation and trajectory analysis , 2001 .

[40]  Joan-Emma Shea,et al.  Folding Landscapes of the Alzheimer Amyloid-β(12-28) Peptide , 2006 .

[41]  J. Brewer,et al.  Solution NMR Studies of the Aβ(1−40) and Aβ(1−42) Peptides Establish that the Met35 Oxidation State Affects the Mechanism of Amyloid Formation , 2004 .

[42]  Satoshi Takahashi,et al.  Direct Observation of Aβ Amyloid Fibril Growth and Inhibition , 2004 .

[43]  J. Hardy,et al.  Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). , 1990, Science.

[44]  Yundong Wu,et al.  A strand-loop-strand structure is a possible intermediate in fibril elongation: long time simulations of amyloid-beta peptide (10-35). , 2005, Journal of the American Chemical Society.

[45]  N Casey,et al.  Residual structure in the Alzheimer's disease peptide: probing the origin of a central hydrophobic cluster. , 1998, Folding & design.

[46]  Ronald Wetzel,et al.  Kinetic analysis of beta-amyloid fibril elongation. , 2004, Analytical biochemistry.

[47]  J R Ghilardi,et al.  In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics. , 1996, Biochemistry.